In a report released today, Liisa Bayko from Evercore ISI maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price ...

Evercore ISI analyst Samir Khanal maintained a Hold rating on Macerich (MAC – Research Report) today and set a price target of $20.00. The ...

Evercore ISI reissued their outperform rating on shares of Marsh & McLennan Companies (NYSE:MMC – Free Report) in a report ...

Evercore ISI assumed coverage on shares of Life Time Group (NYSE:LTH – Free Report) in a research note issued to investors on ...

SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- . (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at ...

CrowdStrike (CRWD) shares slipped 1% on Monday, even as investment firm Evercore ISI upped its price target on the ...

Sarah Bianchi, Evercore ISI public policy chief strategist, joins 'Squawk Box' to discuss President-elect Trump's nomination ...

On a Zoom call last month from California, BridgeBio CEO Neil Kumar needled a colleague about the remote possibility of the ...

We recently published a list of 15 AI News You Should Pay Attention To. In this article, we are going to take a look at where ...

Fintel reports that on November 22, 2024, Evercore ISI Group initiated coverage of Edgewise Therapeutics (NasdaqGS:EWTX) with ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”) today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 7th ...